Clinical Trial: Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT04137120) titled 'Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice' on Oct. 22.

Brief Summary: The study aims to collect data on the safety and use of intravitreal aflibercept injections into the eye for the treatment of eye disorders that cause blurred vision or a blind spot due to abnormal or blocked blood vessels. Data will be collected from patients who are being treated for such eye disorders in Mexican routine clinical practice.

Study Type: Observational

Condition: Retinal Disease

Intervention: Drug: Aflibercept (BAY86-5321, Eylea)...